Literature DB >> 7196764

Metabolism of hydralazine in man. Investigation of features relevant to drug safety, Part I.

K Schmid, W Küng, W Riess, C T Dollery, S J Harland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7196764

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  4 in total

1.  Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.

Authors:  P Brunel; J B Lecaillon; T T Guyene; P Imhof; J Ménard
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

2.  Endralazine - a new hydralazine-like antihypertensive with high systemic bioavailability.

Authors:  P A Reece; I Cozamanis; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

4.  Preparative isolation and purification of urinary conjugates in antipyrine metabolism in man and rat.

Authors:  J Böttcher; H Bässmann; R Schüppel; W D Lehmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.